<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Schizophrenia</title><link>http://www.unboundmedicine.com/medline/ebm/research/Schizophrenia</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Association of AKT1 with verbal learning, verbal memory, and regional cortical gray matter density in twins.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19051289/full_citation/Association_of_AKT1_with_verbal_learning_verbal_memory_and_regional_cortical_gray_matter_density_in_twins_</link><description>Pietiläinen OP, Paunio T, Loukola A, et al. <br/><span class="title">Association of AKT1 with verbal learning, verbal memory, and regional cortical gray matter density in twins. [JOURNAL ARTICLE]</span><br/><span class="source" title="American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics">Am J Med Genet B Neuropsychiatr Genet 2008 Dec 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19051289/abstract/Association_of_AKT1_with_verbal_learning_verbal_memory_and_regional_cortical_gray_matter_density_in_twins_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19051289/full_citation/Association_of_AKT1_with_verbal_learning_verbal_memory_and_regional_cortical_gray_matter_density_in_twins_">Full Citation</a></description></item><item><title>Association study between glutathione S-transferase GST-M1, GST-T1, and GST-P1 polymorphisms and tardive dyskinesia.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19051221/full_citation/Association_study_between_glutathione_S_transferase_GST_M1_GST_T1_and_GST_P1_polymorphisms_and_tardive_dyskinesia_</link><description>Kang SG, Lee HJ, Choi JE, et al. <br/><span class="title">Association study between glutathione S-transferase GST-M1, GST-T1, and GST-P1 polymorphisms and tardive dyskinesia. [JOURNAL ARTICLE]</span><br/><span class="source" title="Human psychopharmacology">Hum Psychopharmacol 2008 Dec 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19051221/abstract/Association_study_between_glutathione_S_transferase_GST_M1_GST_T1_and_GST_P1_polymorphisms_and_tardive_dyskinesia_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19051221/full_citation/Association_study_between_glutathione_S_transferase_GST_M1_GST_T1_and_GST_P1_polymorphisms_and_tardive_dyskinesia_">Full Citation</a></description></item><item><title>[Frequency of Remission in Schizophrenia Patients at One Year Follow-Up.]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19051158/full_citation/[Frequency_of_Remission_in_Schizophrenia_Patients_at_One_Year_Follow_Up_]</link><description>Zimmermann J, Wolter A, Hannöver W, et al. <br/><span class="title">[Frequency of Remission in Schizophrenia Patients at One Year Follow-Up.] [JOURNAL ARTICLE]</span><br/><span class="source" title="Psychiatrische Praxis">Psychiatr Prax 2008 Dec 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19051158/abstract/[Frequency_of_Remission_in_Schizophrenia_Patients_at_One_Year_Follow_Up_]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19051158/full_citation/[Frequency_of_Remission_in_Schizophrenia_Patients_at_One_Year_Follow_Up_]">Full Citation</a></description></item><item><title>Design of potent GlyT1 inhibitors: In vitro and in vivo profiles.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19051137/full_citation/Design_of_potent_GlyT1_inhibitors:_In_vitro_and_in_vivo_profiles_</link><description>Bridges TM, Williams R, Lindsley CW <br/><span class="title">Design of potent GlyT1 inhibitors: In vitro and in vivo profiles. [Journal Article]</span><br/><span class="source" title="Current opinion in molecular therapeutics">Curr Opin Mol Ther 2008 Dec; 10(6):591-601.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19051137/abstract/Design_of_potent_GlyT1_inhibitors:_In_vitro_and_in_vivo_profiles_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19051137/full_citation/Design_of_potent_GlyT1_inhibitors:_In_vitro_and_in_vivo_profiles_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19051137/Design_of_potent_GlyT1_inhibitors:_In_vitro_and_in_vivo_profiles_">Find Related Articles</a> </description></item><item><title>A 15q13.3 microdeletion segregating with autism.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19050728/full_citation/A_15q13_3_microdeletion_segregating_with_autism_</link><description>Pagnamenta AT, Wing K, Akha ES, et al. <br/><span class="title">A 15q13.3 microdeletion segregating with autism. [JOURNAL ARTICLE]</span><br/><span class="source" title="European journal of human genetics : EJHG">Eur J Hum Genet 2008 Dec 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19050728/abstract/A_15q13_3_microdeletion_segregating_with_autism_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19050728/full_citation/A_15q13_3_microdeletion_segregating_with_autism_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19050728/A_15q13_3_microdeletion_segregating_with_autism_">Find Related Articles</a> </description></item><item><title>Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19050712/full_citation/Perceiving_is_believing:_a_Bayesian_approach_to_explaining_the_positive_symptoms_of_schizophrenia_</link><description>Fletcher PC, Frith CD <br/><span class="title">Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia. [JOURNAL ARTICLE]</span><br/><span class="source" title="Nature reviews. Neuroscience">Nat Rev Neurosci 2008 Dec 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19050712/abstract/Perceiving_is_believing:_a_Bayesian_approach_to_explaining_the_positive_symptoms_of_schizophrenia_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19050712/full_citation/Perceiving_is_believing:_a_Bayesian_approach_to_explaining_the_positive_symptoms_of_schizophrenia_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19050712/Perceiving_is_believing:_a_Bayesian_approach_to_explaining_the_positive_symptoms_of_schizophrenia_">Find Related Articles</a> </description></item><item><title>Variability of the in vivo metabolism of clozapine.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19050412/full_citation/Variability_of_the_in_vivo_metabolism_of_clozapine_</link><description>Raedler TJ, Hinkelmann K, Wiedemann K <br/><span class="title">Variability of the in vivo metabolism of clozapine. [Journal Article]</span><br/><span class="source" title="Clinical neuropharmacology">Clin Neuropharmacol 2008 Nov-Dec; 31(6):347-52.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19050412/abstract/Variability_of_the_in_vivo_metabolism_of_clozapine_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19050412/full_citation/Variability_of_the_in_vivo_metabolism_of_clozapine_">Full Citation</a></description></item><item><title>Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19050409/full_citation/Antipsychotic_polypharmacy_in_patients_with_schizophrenia_in_a_brief_hospitalization_unit_</link><description>Lerma-Carrillo I, de Pablo Brühlmann S, Del Pozo ML, et al. <br/><span class="title">Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit. [Journal Article]</span><br/><span class="source" title="Clinical neuropharmacology">Clin Neuropharmacol 2008 Nov-Dec; 31(6):319-32.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19050409/abstract/Antipsychotic_polypharmacy_in_patients_with_schizophrenia_in_a_brief_hospitalization_unit_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19050409/full_citation/Antipsychotic_polypharmacy_in_patients_with_schizophrenia_in_a_brief_hospitalization_unit_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19050409/Antipsychotic_polypharmacy_in_patients_with_schizophrenia_in_a_brief_hospitalization_unit_">Find Related Articles</a> </description></item><item><title>Old and New Pharmacology: Positive Allosteric Modulation of the {alpha}7 Nicotinic Acetylcholine Receptor by the 5-HT2B/C Receptor Antagonist SB-206553.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19050173/full_citation/Old_and_New_Pharmacology:_Positive_Allosteric_Modulation_of_the_{alpha}7_Nicotinic_Acetylcholine_Receptor_by_the_5_HT2B/C_Receptor_Antagonist_SB_206553_</link><description>Dunlop J, Lock T, Jow B, et al. <br/><span class="title">Old and New Pharmacology: Positive Allosteric Modulation of the {alpha}7 Nicotinic Acetylcholine Receptor by the 5-HT2B/C Receptor Antagonist SB-206553. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Journal of pharmacology and experimental therapeutics">J Pharmacol Exp Ther 2008 Dec 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19050173/abstract/Old_and_New_Pharmacology:_Positive_Allosteric_Modulation_of_the_{alpha}7_Nicotinic_Acetylcholine_Receptor_by_the_5_HT2B/C_Receptor_Antagonist_SB_206553_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19050173/full_citation/Old_and_New_Pharmacology:_Positive_Allosteric_Modulation_of_the_{alpha}7_Nicotinic_Acetylcholine_Receptor_by_the_5_HT2B/C_Receptor_Antagonist_SB_206553_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19050173/Old_and_New_Pharmacology:_Positive_Allosteric_Modulation_of_the_{alpha}7_Nicotinic_Acetylcholine_Receptor_by_the_5_HT2B/C_Receptor_Antagonist_SB_206553_">Find Related Articles</a> </description></item><item><title>The coding-synonymous polymorphism rs1045280 (Ser280Ser) in beta-arrestin 2 (ARRB2) gene is associated with tardive dyskinesia in Chinese patients with schizophrenia.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19049562/full_citation/The_coding_synonymous_polymorphism_rs1045280__Ser280Ser__in_beta_arrestin_2__ARRB2__gene_is_associated_with_tardive_dyskinesia_in_Chinese_patients_with_schizophrenia_</link><description>Liou YJ, Wang YC, Chen JY, et al. <br/><span class="title">The coding-synonymous polymorphism rs1045280 (Ser280Ser) in beta-arrestin 2 (ARRB2) gene is associated with tardive dyskinesia in Chinese patients with schizophrenia. [Journal Article]</span><br/><span class="source" title="European journal of neurology : the official journal of the European Federation of Neurological Societies">Eur J Neurol 2008 Dec; 15(12):1406-8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19049562/abstract/The_coding_synonymous_polymorphism_rs1045280__Ser280Ser__in_beta_arrestin_2__ARRB2__gene_is_associated_with_tardive_dyskinesia_in_Chinese_patients_with_schizophrenia_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19049562/full_citation/The_coding_synonymous_polymorphism_rs1045280__Ser280Ser__in_beta_arrestin_2__ARRB2__gene_is_associated_with_tardive_dyskinesia_in_Chinese_patients_with_schizophrenia_">Full Citation</a></description></item></channel></rss>